Back |
home / stock / espr / espr message board
Subject | By | Source | When |
---|---|---|---|
Yikes Just finished adding 40k more | Johnny_C | investorshub | 03/12/2020 5:49:42 PM |
A small correction before a CNN Higher high. GLTA | keepemcloser | investorshub | 02/27/2020 2:29:15 AM |
We believe the stock will continue in the green | keepemcloser | investorshub | 02/25/2020 1:09:39 PM |
One of the few stocks in the green today | Johnny_C | investorshub | 02/24/2020 10:37:23 PM |
Esperion Announces FDA Approval of NEXLETOL(TM) (bempedoic acid) | crudeoil24 | investorshub | 02/23/2020 4:34:46 PM |
Great news on all media networks!!!!! | crudeoil24 | investorshub | 02/23/2020 2:34:27 PM |
Getting close to $80. Think sell half | Johnny_C | investorshub | 02/14/2020 10:13:44 PM |
Great action this morning,We are new here,anyone estimate | keepemcloser | investorshub | 02/03/2020 2:40:34 PM |
Almost there. Think I will wait till | Johnny_C | investorshub | 01/17/2020 2:23:57 PM |
I had some great trades with this one. | Johnny_C | investorshub | 12/03/2019 9:03:59 PM |
I hope so. I missed my sell opportunity | drusso12345 | investorshub | 11/13/2019 2:42:02 PM |
Looking better here! | Johnny_C | investorshub | 11/13/2019 2:38:33 PM |
Going down! Earnings? This company is not making | drusso12345 | investorshub | 08/04/2019 7:45:18 PM |
Hope yall loading up before earnings!!! Buy buy buy | T695 | investorshub | 08/04/2019 6:03:46 PM |
$45 calls 8-16 | T695 | investorshub | 08/02/2019 5:42:48 PM |
News: $ESPR Esperion to Host Analyst and Investor | whytestocks | investorshub | 05/07/2019 12:01:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that the company will be participating in the followin...
ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website . Jefferies Global Healthcare Confer...
– NILEMDO (bempedoic acid), a First-In-Class, Oral Treatment and NUSTENDI (bempedoic Acid / Ezetimibe Fixed-Dose Combination) Receive Label Update Approval from The European Commission as Treatments to Reduce Cardiovascular Risk by Lowering Low-Density Lipoprotein Cholesterol (LDL-C) Level...